The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Hemophilia, vitamin k deficiency, and disseminated intravascular coagulation are some of the factors responsible for blood clotting disorders that not only requires relevant treatment, but also timely and affordable diagnosis.
The global Hemostasis Diagnostics market was valued at US$ 568.4 million in 2023 and is anticipated to reach US$ 796.5 million by 2030, witnessing a CAGR of 4.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Hemostasis Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hemostasis Diagnostics.
Report Scope
The Hemostasis Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hemostasis Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hemostasis Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company (Partial List)
- Abbott
- Thermo Fisher Scientific
- Roche
- Nihon Kohden
- Sysmex
- Siemens Healthineers
- Instrumentation Laboratory
- Beckman Coulter
- Grifols
Segment by Type
- Laboratory Analyzers
- Point-of-Care Testing Systems
Segment by Application
- Hospitals
- Diagnostic Centers
- Others
Consumption by Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Netherlands)
- Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
- Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hemostasis Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemostasis Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Laboratory Analyzers
1.2.3 Point-of-Care Testing Systems
1.3 Market by Application
1.3.1 Global Hemostasis Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemostasis Diagnostics Market Perspective (2019-2030)
2.2 Hemostasis Diagnostics Growth Trends by Region
2.2.1 Global Hemostasis Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hemostasis Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 Hemostasis Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 Hemostasis Diagnostics Market Dynamics
2.3.1 Hemostasis Diagnostics Industry Trends
2.3.2 Hemostasis Diagnostics Market Drivers
2.3.3 Hemostasis Diagnostics Market Challenges
2.3.4 Hemostasis Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hemostasis Diagnostics Players by Revenue
3.1.1 Global Top Hemostasis Diagnostics Players by Revenue (2019-2024)
3.1.2 Global Hemostasis Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global Hemostasis Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hemostasis Diagnostics Revenue
3.4 Global Hemostasis Diagnostics Market Concentration Ratio
3.4.1 Global Hemostasis Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemostasis Diagnostics Revenue in 2023
3.5 Hemostasis Diagnostics Key Players Head office and Area Served
3.6 Key Players Hemostasis Diagnostics Product Solution and Service
3.7 Date of Enter into Hemostasis Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemostasis Diagnostics Breakdown Data by Type
4.1 Global Hemostasis Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global Hemostasis Diagnostics Forecasted Market Size by Type (2025-2030)
5 Hemostasis Diagnostics Breakdown Data by Application
5.1 Global Hemostasis Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global Hemostasis Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hemostasis Diagnostics Market Size (2019-2030)
6.2 North America Hemostasis Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hemostasis Diagnostics Market Size by Country (2019-2024)
6.4 North America Hemostasis Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hemostasis Diagnostics Market Size (2019-2030)
7.2 Europe Hemostasis Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hemostasis Diagnostics Market Size by Country (2019-2024)
7.4 Europe Hemostasis Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hemostasis Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific Hemostasis Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hemostasis Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific Hemostasis Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hemostasis Diagnostics Market Size (2019-2030)
9.2 Latin America Hemostasis Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hemostasis Diagnostics Market Size by Country (2019-2024)
9.4 Latin America Hemostasis Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hemostasis Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa Hemostasis Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hemostasis Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa Hemostasis Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Hemostasis Diagnostics Introduction
11.1.4 Abbott Revenue in Hemostasis Diagnostics Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Hemostasis Diagnostics Introduction
11.2.4 Thermo Fisher Scientific Revenue in Hemostasis Diagnostics Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Hemostasis Diagnostics Introduction
11.3.4 Roche Revenue in Hemostasis Diagnostics Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Nihon Kohden
11.4.1 Nihon Kohden Company Detail
11.4.2 Nihon Kohden Business Overview
11.4.3 Nihon Kohden Hemostasis Diagnostics Introduction
11.4.4 Nihon Kohden Revenue in Hemostasis Diagnostics Business (2019-2024)
11.4.5 Nihon Kohden Recent Development
11.5 Sysmex
11.5.1 Sysmex Company Detail
11.5.2 Sysmex Business Overview
11.5.3 Sysmex Hemostasis Diagnostics Introduction
11.5.4 Sysmex Revenue in Hemostasis Diagnostics Business (2019-2024)
11.5.5 Sysmex Recent Development
11.6 Siemens Healthineers
11.6.1 Siemens Healthineers Company Detail
11.6.2 Siemens Healthineers Business Overview
11.6.3 Siemens Healthineers Hemostasis Diagnostics Introduction
11.6.4 Siemens Healthineers Revenue in Hemostasis Diagnostics Business (2019-2024)
11.6.5 Siemens Healthineers Recent Development
11.7 Instrumentation Laboratory
11.7.1 Instrumentation Laboratory Company Detail
11.7.2 Instrumentation Laboratory Business Overview
11.7.3 Instrumentation Laboratory Hemostasis Diagnostics Introduction
11.7.4 Instrumentation Laboratory Revenue in Hemostasis Diagnostics Business (2019-2024)
11.7.5 Instrumentation Laboratory Recent Development
11.8 Beckman Coulter
11.8.1 Beckman Coulter Company Detail
11.8.2 Beckman Coulter Business Overview
11.8.3 Beckman Coulter Hemostasis Diagnostics Introduction
11.8.4 Beckman Coulter Revenue in Hemostasis Diagnostics Business (2019-2024)
11.8.5 Beckman Coulter Recent Development
11.9 Grifols
11.9.1 Grifols Company Detail
11.9.2 Grifols Business Overview
11.9.3 Grifols Hemostasis Diagnostics Introduction
11.9.4 Grifols Revenue in Hemostasis Diagnostics Business (2019-2024)
11.9.5 Grifols Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
